Lyell Immunopharma, Inc. Other Non-Current Liabilities
Lyell Immunopharma, Inc. (LYEL) had Other Non-Current Liabilities of $537.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $537.00K.
- 2026-03-31: Other Liabilities, Noncurrent $527.00K.
- 2025-12-31: Other Liabilities, Noncurrent $517.00K.
- 2025-09-30: Other Liabilities, Noncurrent $2.68M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $537.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $527.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $517.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.68M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.03M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $3.14M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.25M 10-K · filed 2026-03-12 |
| 2024-09-30 | $3.56M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.44M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $3.55M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $3.66M 10-K · filed 2025-03-11 |
| 2023-09-30 | $3.78M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.89M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.11M 10-K · filed 2024-02-28 |
| 2022-09-30 | $4.23M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.45M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $4.57M 10-K · filed 2023-02-28 |
| 2021-09-30 | $5.01M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $900.00K 10-Q · filed 2021-08-12 |
| 2020-12-31 | $532.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |